NCT00813800View on ClinicalTrials.gov

Varenicline in Bipolar Depressed Patients

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

February 28, 2011

Conditions

SmokingBipolar DisorderDepression

Interventions

DRUG

Varenicline

Varenicline (Chantix®, Pfizer) is an oral medication with a recommended dosage of 0.5 mg once daily for 3 days, increasing to 0.5 mg twice daily for days 4-7, and then to the maintenance dose of 1 mg twice daily for the 12 weeks of treatment.

Trial Locations (1)

55905

Mayo Clinic, Rochester